Osaic Holdings’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $33.4K | Buy |
2,474
+332
| +15% | +$4.48K | ﹤0.01% | 4987 |
|
2025
Q1 | $19K | Sell |
2,142
-522
| -20% | -$4.63K | ﹤0.01% | 5364 |
|
2024
Q4 | $36.5K | Sell |
2,664
-458
| -15% | -$6.28K | ﹤0.01% | 4899 |
|
2024
Q3 | $85.5K | Buy |
3,122
+696
| +29% | +$19.1K | ﹤0.01% | 4331 |
|
2024
Q2 | $59.3K | Buy |
2,426
+42
| +2% | +$1.03K | ﹤0.01% | 4515 |
|
2024
Q1 | $50.8K | Sell |
2,384
-7,092
| -75% | -$151K | ﹤0.01% | 4730 |
|
2023
Q4 | $181K | Sell |
9,476
-6,648
| -41% | -$127K | ﹤0.01% | 4001 |
|
2023
Q3 | $259K | Buy |
16,124
+6,531
| +68% | +$105K | ﹤0.01% | 3806 |
|
2023
Q2 | $222K | Buy |
9,593
+380
| +4% | +$8.81K | ﹤0.01% | 3812 |
|
2023
Q1 | $214K | Sell |
9,213
-12,890
| -58% | -$299K | ﹤0.01% | 3816 |
|
2022
Q4 | $321K | Buy |
22,103
+288
| +1% | +$4.18K | ﹤0.01% | 3450 |
|
2022
Q3 | $417K | Buy |
21,815
+991
| +5% | +$18.9K | ﹤0.01% | 3066 |
|
2022
Q2 | $379K | Buy |
20,824
+1,459
| +8% | +$26.6K | ﹤0.01% | 3210 |
|
2022
Q1 | $488K | Buy |
19,365
+2,272
| +13% | +$57.3K | ﹤0.01% | 3244 |
|
2021
Q4 | $472K | Sell |
17,093
-5,418
| -24% | -$150K | ﹤0.01% | 3118 |
|
2021
Q3 | $726K | Buy |
22,511
+4,524
| +25% | +$146K | ﹤0.01% | 2648 |
|
2021
Q2 | $551K | Sell |
17,987
-1,988
| -10% | -$60.9K | ﹤0.01% | 2926 |
|
2021
Q1 | $609K | Buy |
19,975
+6,504
| +48% | +$198K | ﹤0.01% | 2671 |
|
2020
Q4 | $266K | Sell |
13,471
-618
| -4% | -$12.2K | ﹤0.01% | 3219 |
|
2020
Q3 | $184K | Sell |
14,089
-211
| -1% | -$2.76K | ﹤0.01% | 3326 |
|
2020
Q2 | $162K | Buy |
14,300
+4,815
| +51% | +$54.5K | ﹤0.01% | 3320 |
|
2020
Q1 | $136K | Buy |
+9,485
| New | +$136K | ﹤0.01% | 3214 |
|